Literature DB >> 9185911

bcl-2 expression in pilomatricoma.

S Farrier1, M Morgan.   

Abstract

Pilomatricoma is a distinctive tumor characterized by a dual population of proliferating basophilic cells and diagnostic shadow cells, believed to arise from the hair matrix. The normal hair matrix undergoes defined cycles of growth (anagen), regression (catagen), and resting (telogen) that are regulated by programmed cell death (apoptosis). bcl-2 is a proto-oncogene that helps to suppress apoptosis in both benign and malignant tumors. In addition, both apoptosis and bel-2 are critical factors in normal hair follicle development. In order to clarify the role of bcl-1, we used immunohistochemical means to study 10 cases of histologically proven pilomatricoma for bcl-2 expression. The study design included both positive and negative controls. All of the pilomatricomas in our series were strongly decorated by bcl-2 immunostaining. Based on our findings of increased bcl-2 staining, we concluded that the faulty suppression of apoptosis contributes to the pathogenesis of pilomatricoma.

Entities:  

Mesh:

Year:  1997        PMID: 9185911     DOI: 10.1097/00000372-199706000-00009

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  3 in total

1.  Pilomatrixoma of the spermatic cord.

Authors:  H C Godbole; J C Gingell
Journal:  Ir J Med Sci       Date:  2002 Oct-Dec       Impact factor: 1.568

2.  Ghost cells: A journey in the dark….

Authors:  Monica Mehendiratta; Kundendu A Bishen; Karen Boaz; Yulia Mathias
Journal:  Dent Res J (Isfahan)       Date:  2012-12

3.  No Evidence of Abnormal Expression of Beta-Catenin and Bcl-2 Proteins in Pilomatricoma as One Clinical Feature of Tetrasomy 9p Syndrome.

Authors:  Chariyawan Charalsawadi; Sasipong Trongnit; Kanoot Jaruthamsophon; Juthamas Wirojanan; Somchit Jaruratanasirikul; Anupong Nitiruangjaras; Pornprot Limprasert
Journal:  Int J Pediatr       Date:  2021-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.